Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2024-04-15 00:00:00 ET · period of report 2024-04-11 · accession 0001493152-24-014512 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-15 | 2024-04-11 | IMDX | Riggs Josh | CEO, Pres, Dir | P - Purchase | $2.95 | +3,390 | 3,505 | +2,948% | +$10.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2024-04-11 | P | A | 3,390 | $2.95 | 3,505 | D | — | — | (F1) Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private offering. |